Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) Short Interest Update

Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) was the target of a large increase in short interest in July. As of July 15th, there was short interest totaling 10,281 shares, an increase of 165.0% from the June 30th total of 3,880 shares. Approximately 2.9% of the shares of the stock are sold short. Based on an average daily volume of 48,072 shares, the days-to-cover ratio is presently 0.2 days.

Defiance Daily Target 2X Long LMND ETF Price Performance

Defiance Daily Target 2X Long LMND ETF stock traded down $6.47 during mid-day trading on Wednesday, reaching $7.63. The company had a trading volume of 292,140 shares, compared to its average volume of 45,090. Defiance Daily Target 2X Long LMND ETF has a fifty-two week low of $6.90 and a fifty-two week high of $55.00. The company has a current ratio of 8.37, a quick ratio of 6.08 and a debt-to-equity ratio of 0.52. The company has a market cap of $2.90 million, a P/E ratio of 14.96 and a beta of -9.04. The business has a fifty day simple moving average of $14.91 and a 200 day simple moving average of $19.79.

Defiance Daily Target 2X Long LMND ETF Company Profile

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays.